Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.conduitpharma.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

topstockalerts Mar. 13 at 9:45 PM

After Hours Top Gainers PT2 $CDT $AURE $CVKD $RBNE $TURB

0 · Reply

ka1954 Mar. 13 at 7:57 PM

$CDT piece of crap. another 20% cut. useless stock

0 · Reply

Sam201 Mar. 13 at 7:21 PM

$CDT another 2k shares. 15k. Final Vote on Monday so this complete shakeup

1 · Reply

DORO879 Mar. 13 at 9:05 AM

$CDT vote what you choice ?

0 · Reply

trading_momentum_x Mar. 13 at 1:34 AM

$CDT bottom play with an inside candle today. Resistance at 70 cents as well as bear channel trend line POC, and higher resistance at 1.17. Ticker is in oversold territory and daily macd currently crossing

0 · Reply

DARKP00L Mar. 12 at 12:47 PM

$CDT 08:40 on Mar. 12 2026 CDT Equity Announces Sarborg Expands Its AI Signature Agent Platform Through Curation Of Rare Disease Signature Database #tradeideas

0 · Reply

ClearBlueWaters Mar. 12 at 12:39 PM

$CDT https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl163203.pdf

0 · Reply

Sam201 Mar. 11 at 2:36 PM

$CDT another 3k to 13k shares! This one is very risky n load knowing you may lose significantly. On the plus side- tiny float!

0 · Reply

Jeffartist Mar. 11 at 9:57 AM

$RNWF $IXHL $CDT $OPEN

0 · Reply

Jeffartist Mar. 11 at 1:11 AM

$RNWF $IXHL $CDT $OPEN

0 · Reply

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

Mar 5, 2026, 8:30 AM EST - 10 days ago

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

Mar 4, 2026, 8:30 AM EST - 11 days ago

CDT Positions for Transformational Growth

Feb 24, 2026, 8:30 AM EST - 19 days ago

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

Feb 20, 2026, 8:30 AM EST - 23 days ago

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

Jan 2, 2026, 8:30 AM EST - 2 months ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 5 months ago

CDT Equity Increases Bitcoin Holding

Oct 9, 2025, 8:00 AM EDT - 5 months ago

CDT Equity Inc. Announces Reverse Stock Split

Sep 17, 2025, 8:30 AM EDT - 6 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 7 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 7 months ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 8 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

topstockalerts Mar. 13 at 9:45 PM

After Hours Top Gainers PT2 $CDT $AURE $CVKD $RBNE $TURB

0 · Reply

ka1954 Mar. 13 at 7:57 PM

$CDT piece of crap. another 20% cut. useless stock

0 · Reply

Sam201 Mar. 13 at 7:21 PM

$CDT another 2k shares. 15k. Final Vote on Monday so this complete shakeup

1 · Reply

DORO879 Mar. 13 at 9:05 AM

$CDT vote what you choice ?

0 · Reply

trading_momentum_x Mar. 13 at 1:34 AM

0 · Reply

DARKP00L Mar. 12 at 12:47 PM

$CDT 08:40 on Mar. 12 2026 CDT Equity Announces Sarborg Expands Its AI Signature Agent Platform Through Curation Of Rare Disease Signature Database #tradeideas

0 · Reply

ClearBlueWaters Mar. 12 at 12:39 PM

$CDT https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl163203.pdf

0 · Reply

Sam201 Mar. 11 at 2:36 PM

$CDT another 3k to 13k shares! This one is very risky n load knowing you may lose significantly. On the plus side- tiny float!

0 · Reply

Jeffartist Mar. 11 at 9:57 AM

$RNWF $IXHL $CDT $OPEN

0 · Reply

Jeffartist Mar. 11 at 1:11 AM

$RNWF $IXHL $CDT $OPEN

0 · Reply

silentsparrow Mar. 10 at 11:30 PM

$RNWF hooking up a fusion device to power a city in 2026!!! Thats insane. 1st of its kind tech!!! LFGOOOO. Plenty of dd on the page! Im not asking you to buy a million shares. Just look into it $IXHL $CDT $OPEN Come on open army lets make a fusion army and get ticher than wolf of walstreet himself!!!

2 · Reply

falcon630 Mar. 10 at 5:07 PM

$CDT another rs and more dilution to follow. I promise you..

1 · Reply

vmkhc Mar. 6 at 9:15 PM

$CDT RS Vote March 17 2026 https://www.sec.gov/Archives/edgar/data/1896212/000149315226009143/formdef14a.htm

0 · Reply

Nevilhch Mar. 4 at 11:28 PM

$CDT Every time this company says in a press conference that it wants to generate value for the shareholder... 😂😅😂😅😂 get ready, it's going to hell, like there's no tomorrow jeje

0 · Reply

Bullish_Bearish88 Mar. 4 at 9:21 PM

$CDT still garbage and will always be garbage . They will R/S again and they got millions of shares to dump.

0 · Reply

StockNews_Live Mar. 4 at 1:34 PM

$CDT CDT Equity Inc. advances multiple initiatives to enhance shareholder value and expand its strategic footprint. The Company continues to develop and expand its pharmaceutical asset portfolio, including…

0 · Reply

BrokeBoiTrading Feb. 28 at 12:04 AM

$CDT another split? jesus thank god i left this about two splits ago holy. i suffered the first one, so this is number 4 in less than a year.

1 · Reply

BrokeBoiTrading Feb. 28 at 12:03 AM

$CDT Why is Andrew Regan still making deals with himself? He is also the director of Sarborg, is that not conflict of interest?

0 · Reply

Nevilhch Feb. 25 at 5:24 PM

$CDT Every week you check their page, 1 million more shares appear that have been diluted.

0 · Reply

Nevilhch Feb. 25 at 12:07 PM

$CDT And now eToro won't let me short this crap... honestly, it's the worst stock on the market🤨🤨🤨🤦

2 · Reply

ClearBlueWaters Feb. 24 at 10:24 PM

$CDT https://capedge.com/filing/1896212/0001493152-26-007906/CDT-8K

1 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A